OptiBiotix Health (OPTI)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

17.75p
   
  • Change Today:
    -0.25p
  • 52 Week High: 39.00
  • 52 Week Low: 6.00
  • Currency: UK Pounds
  • Shares Issued: 97.94m
  • Volume: 0
  • Market Cap: £17.38m

OptiBiotix Health appoints ProBiotix sales manager for Europe

By Josh White

Date: Wednesday 04 Dec 2019

LONDON (ShareCast) - (Sharecast News) - Life sciences business OptiBiotix Health announced the appointment of Mikkel Hvid-Hansen as the European sales leader of its wholly-owned subsidiary ProBiotix Health.
The AIM-traded firm said Hvid-Hansen was joining ProBiotix from a position as international sales manager from Cell Biotech, which is a Korean probiotic company selling bulk ingredients and finished products internationally.

Prior to joining Cell Biotech, he spent six years as international sales manager at Bifodan, where he had responsibility for the sales of several probiotic over-the-counter drugs.

Previously, Hvid-Hansen also worked for Lallemand, the world's third-largest probiotic company, between 1998 and 2006, and Eraco between 1995 and 1998.

OptiBiotix said Hvid-Hansen would bring "extensive experience" of commercialising probiotics products and technologies, a wide network of industry contacts, and a strong track record of rapidly growing sales.

He would be based in Denmark to support existing sales in Europe, and extend the market opportunities for its 'LPLDL' within the European probiotic supplement, food, and dairy markets.

"Mikkel's experience and track record of launching new products and growing sales within Europe brings over 20 years of commercial and probiotic industry expertise to OptiBiotix's wholly owned probiotic subsidiary, ProBiotix Health," said ProBiotix chief executive officer Steve Prescott.

"His network of contacts provides access to key customers which we hope will continue to drive revenue growth of LPLDL in supplement, food and pharmaceutical products around the world.

"We are delighted that Mikkel has joined ProBiotix Health at such an exciting stage of its development transforming the company from research and development to commercial sales focussed."

At 1454 GMT, shares in OptiBiotix Health were down 0.6% at 49.7p.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

OPTI Market Data

Currency UK Pounds
Share Price 17.75p
Change Today -0.25p
% Change -1.39 %
52 Week High 39.00
52 Week Low 6.00
Volume 0
Shares Issued 97.94m
Market Cap £17.38m

OPTI Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
60.16% above the market average60.16% above the market average60.16% above the market average60.16% above the market average60.16% above the market average
92.16% above the sector average92.16% above the sector average92.16% above the sector average92.16% above the sector average92.16% above the sector average
Price Trend
16.42% below the market average16.42% below the market average16.42% below the market average16.42% below the market average16.42% below the market average
33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average
Income Not Available
Growth
96.72% below the market average96.72% below the market average96.72% below the market average96.72% below the market average96.72% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average

OPTI Dividends

No dividends found

Trades for --2024

Time Volume / Share Price
0 @ 0.000p

OPTI Key Personnel

CEO Stephen O'Hara
Finance Director Graham Myers

Top of Page